3.19
8.14%
0.24
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.86%
1.618
|
1.795 | 6.015 | 4.243 | 7.042 |
Operating Income/Loss |
9.86%
-1.618
|
-1.795 | -6.015 | -4.243 | -7.042 |
Nonoperating Income/Loss |
24.75%
0.076
|
0.101 | 0.107 | 0.062 | 0.088 |
Income/Loss From Continuing Operations Before Tax |
127.36%
-1.542
|
5.636 | -5.908 | -4.181 | -6.954 |
Income/Loss From Continuing Operations After Tax |
8.97%
-1.542
|
-1.694 | -5.908 | -4.181 | -6.954 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | 13.47 | - | - |
Net Income/Loss
|
8.97%
-1.542
|
-1.694 | 7.566 | -4.181 | -6.954 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
6,295%
2.494
|
0.039 | 2.435 | 2.282 | 0.0435 |
Diluted Average Shares |
6,295%
2.494
|
0.039 | 2.786 | 2.282 | 0.0435 |
Basic Earnings Per Share |
11.43%
-0.62
|
-0.70 | 3.11 | -1.83 | -0.16 |
Diluted Earnings Per Share |
11.43%
-0.62
|
-0.70 | 2.72 | -1.83 | -0.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):